binary options holy grail
stock smasher binary options signals
top us binary options sites
gsm autobot binary options trading system developed by clive hussey
top ten binary options brokers regulat
binary option signal at 2345 should be 135235
best 60 second binary option broke
late night binary options trading
how to trade boundary binary options
binary option trade revie
binary options review scams trading journal software
binary options trading grap
binaryoptionsbrokersreviews
binary trading forex review software download
go binary options trading online platform
basic concepts of binary option trading
60 second adx ema binary options strategy
how old do you have to be to do binary options
what are binary options trading tools
trading binary options in flat and volatile markets
binary options charles schwab
uk binary option trading
binary arbitrages trading softwa
binary option strategy best broker promotion of the month
net mavrik binary options
binary options signals explained
what are the best sites for binary options
binary options 120sec strategy
tag archives binaryoptionsdaily forum
are binary options on the upswing
binary signals pro review options stock signals
binary option forums
the difference between forex and binary options trading
binary options signals software free download signals top 4
opteck binary trading
profit lock binary options strategy
choose the reputed fee binary option signals service provider
sweden binary options brokers
buy binary options blueprint best price
binary option robot torre
60second binary option strategi
short term day trading strategies in binary options
earning on binary options
buy top3binaryoptionsbrokerseconomysize shopping
binary options custom indicator on the eurjpy works very well
binary option methods hair extensio
forex binary options beginners guide
binary options fund management
pros and cons of binary option trading
dogs binary option trades page 2
binary option trading ris
analytics for make a living off binary option
bollinger bands and moving averages used in analysis of binary options
binary options on nadex what strategy should i trade
binary options and online stock trading
binary options account managers and retention experts ref 35101
how to trade 60 second binary options profitab
binary option traders las vegas nv
binary trading 30 year bon
cboe credit event binary options
binary options brokers project pro brokers
the binary options ladder strategy
how to make money online trading 60 second binary options
binary option advice
binary options 10 trades 9 winners
binary options trading strategy earns 1600 in an hour
top binary trading companies
mikes binary options quick guide
binary options breaker system
binary options trading sessions 717 good end to the week
timeless simplest methods for binary options trading
binary options daily market review 1392014
binary option trading robot omni
binary trading book review trade options demo account
option mint trading binary options with mint
binary video
free risk trades at ioption binary option broker
binary options reviews a necessary tool
no deposit reward binary options buying and selling platforms i
binary options trading in
talking about the best binary options strategy
using nadex binary options to trade crude oil
binary options winning strate
binary options signals watchdog
binary options di hamish raw p
how to trade binary options against a bucket shop
forex binary option strategy review options expert signals
trade on binary options and receive instant returns
tag archives binary options regulation
23best binary options broker review and trading system 08122014
binary options win strategy
best binary trading robot
the miracle of the five minute binary option trading
bb12 gold binary option system 2014
binary options 101 home study course
best pro binary signals profit trading review
binaryoptionsnetau professional indicator tutorial
binary option autotrader review is options autotrader a scam dont buy
strategy for angler30 binary options with 30 seconds expiration by ob60
legit proofs honest review by binary option master ktre

Financial Sector Reacts To SCOTUS Ruling

More reaction to the SCOTUS ruling via Associated Press, this time from the financial services sector.

NEW YORK (AP) — Citi Investment Research analyst Carl McDonald:

“The decision to uphold the individual mandate was one of the few Supreme Court outcomes that shouldn’t result in much volatility — The decision essentially maintains the status quo. We can argue the stocks might be off a little, since there was hope the court would eliminate some of the negative aspects of health reform, but at the same time, it’s easy enough to argue for the stocks to rise a bit now that we’ve gotten through this significant overhang.

“The macro picture in the second half of 2012 seems to favor the managed care plans — If President Obama is re-elected, it again affirms to us the status quo that is currently reflected in valuations. If Republicans win in November, we would expect the group to rise up to 20 percent in the aftermath given the favorable impact Republicans could have on 2014 earnings. With the election polls basically 50/50 right now, that’s a pretty compelling risk reward scenario for the group.”

Goldman Sachs analyst Matthew Borsch:

“Managed Care: An incremental negative but may imply less uncertainty: We expect selling pressure on managed care given our belief that investors would have seen an overturn of reform as a better outcome for the sector. However, we think any selling pressure will be modest since this ruling is the outcome most investors had anticipated prior to the oral arguments in late March. Moreover, this ruling implies less uncertainty than any other outcome, in our view, and avoids the ‘mandate only’ outcome we believe many investors saw as ‘worst case.’ Meanwhile, this ruling is net positive for Medicaid names (Amerigroup Corp., Centene Corp., Molina Healthcare Inc., WellCare Health Plans Inc.) since Medicaid coverage expansion survives (even though the Court apparently has given states the ability to ‘opt out’ of the expansion). We maintain our ‘Neutral’ coverage view and 2012-2014 EPS, which already reflect current law, for Medicaid and commercial / Medicare.

Hospitals the ‘net winners’ under this outcome: We expect hospital names will trade up on this ruling as it represents their “best case” outcome, in our view, setting up 2014 to be a good year if the coverage expansion is fully implemented on schedule. However, pressures on the outlook from other sources (e.g., responses to the fiscal cliff) remain and uncertainty over the fate of reform will remain high ahead of elections. We maintain our earnings per share (already reflects current law) for our covered hospital names (HCA Holdings Inc., Community Health Systems Inc., and Tenet Healthcare Corp.).”

FBR Capital Markets analyst Benjamin Salisbury:

“On first read, we view this as most positive for hospitals and somewhat positive for pharma and insurers. It is likely to be viewed most negatively for medical device manufacturers and neutral to somewhat negative for rehab, nursing, and home health. This decision was largely unexpected as consensus expected a repeal of the individual mandate. Although that uncertainty has been alleviated, the law will continue to be a focus in the election and potentially Congress next year.”

A group of Jefferies & Co. analysts:

“A status quo Supreme Court decision provides visibility and clarity on the forward operating environment for both providers and payors. This morning’s rally in providers could be limited as investors turn their focus back to weak fundamentals, the upcoming elections and deficit-reduction initiatives. For payors, we expect better earnings performance in the second quarter (due to soft utilization trends) and Medicare Advantage and Medicaid member growth.”

“With Medicaid expansion AND the individual mandate upheld, the outcome of the Supreme Court decision was slightly better than what most investors had expected (i.e. mandate gone). Having the whole law upheld is driving strength in providers as it keeps key beneficial provisions in place (i.e. those that reduce the uninsured), but we believe the rally will be short-lived. While the Supreme Court decision eliminates a key, long-standing overhang on provider stocks, we believe that investor focus will gradually shift over the next few months to other looming issues such as the elections, the doc fix later this year, and a likely deficit reduction/debt ceiling bill in early 2013, so we expect the momentum in the provider group to be relatively short-lived, particularly as investors in the crowded ‘long hospital’ trade begin to take profits.”

Mizuho Securities analyst Michael Matson

“The Supreme Court has upheld the individual mandate and Medicaid expansion. We think this is neutral for med tech stocks. While the medical device excise tax remains, the individual mandate and Medicaid expansion should lead to a decline in the uninsured during 2014-2016 and an increase in med tech procedures that could partially offset the excise tax.”

BMO Capital Markets analyst Dave Shove:

“Managed Care: No New Surprises – The whole group has been preparing for Patient Protection and Affordable Care Act since its passage, which is the good news. The bad news, for some players, is that the small group and individual market will remain a tough sandbox to play in.

Hospitals: More Insurance Coverage – Medicaid expansion was designed to provide more than 15 million people with healthcare coverage by 2016, which would reduce the amount of uncompensated care that flows through hospitals. Now – without a big stick – the expansion after that is unknown. Profitability and cash flow are poised for medium-term improvement – how much improvement is really the question now.

Pharmacy Benefits Managers: Yawn – As the most insulated group from the reform fallout in 2010, the PBMs remain largely unaffected.”

Barclays Capital analyst C. Anthony Butler:

“This ruling came as a surprise to some investors, who in recent days have been expecting the overturning of the individual mandate if not the entire act. We believe that today’s decision has minimal effect on the fundamentals of the U.S. pharmaceutical companies, and there is unlikely to be any long term effect on the valuations of the sector.

The industry has been impacted by the Patient Protection and Affordable Care Act since its enactment in 2010. In 2011, manufacturers started paying a 50 percent discount to Medicare Part D beneficiaries whose are in the so-called ‘donut hole’ or coverage gap. There were also increased rebates to Medicaid programs. The sector have been paying an industry excise fee — totaling $2.5 billion in 2011 and $2.8 billion in 2012 for the entire sector — which has been recorded as selling, general and administrative expenses. Starting in 2013, those companies with medical device exposure (i.e. Johnson & Johnson, Abbott Laboratories) will need to pay a 2.3 percent deductible tax on U.S. medical device sales.

We expect increased health care coverage in the pool of uninsured Americans (around 35 million) starting in 2014, though the actual volume upside may be lower and more modest then some expect.”

 

Copyright 2012 The Associated Press.

 

Dansette

google